pfizer was alleged to have deceptively marketed drugs for purposes which were not approved by the fda. those actions put patients at risk, cause heart attacks, and death. in addition, allegations of kickbacks to doctors. the subsidiaries pled guilty. we found multiple year schemes to advance the marketing of drugs for purposes which had not been approved by the fda. host: a company like pfizer or eli lilly, do they set out in their board rooms to commit fraud? guest: i do not thing we have ever had someone be as explicit as say it is a crime and i'm looking forward to committee it, but they clearly understand the parameters of the law. in the case of pfizer, they understand that the fda says you cannot market this drug for acute pain, and they went ahead and did it anyway because it increase market share in profits. i would say that executives at pfizer knew what they were doing was illegal. host: before we go to the colors, are the lo guest: they are very sophisticated. it is safer than dealing crack cocaine. we need more resources devoted to combating -- combating fraud problem. hos

the fda -- f a a will release an of this year or early next year a note of proposed rulemaking. at this point they completed aviation rule making committee and they are writing the rules but we have not seen it yet. we have advocated for certainly more time, more recuperative rest time at home than just 24 hours every seven days. but again, more of the complex matrix. but we believe those rest periods have to be protected and certainly expanded in this case. host: is the stronger regulations regarding the number of hours pilots work and fast turnaround? is there concern about reduction in pay? they are paid by air time. guest: it is something we will probably have to address. but we expect the pay hours will be roughly the same as they are today. i think certain operations may reduce some of their monthly flying. one of the things we're asking for is there are a lot of different types of flying. while we were talking mostly about airline passenger flying -- major's and regionals -- there is a huge section of the industry flying cargo, scheduled cargo, on schedule, flying through

the point of going to make here is that we have studies all across that we gather routine at the fda that shows that people often off to drive instead of taking transit because it might save in 10 or 15 minutes on the commute of a great many of those same commuters spend their first half-hour of the morning at their desk answering e-mail, and a certain have to do with the last half-hour of the day at the desk also handling e-mail. when you really think about it, they may spend, save 10 minutes in the commute. but if they got on the bus, or got on the train, and use a handheld device and did that first half-hour and that last half hour on e-mail, they could leave for work at half hour later. they could get home a half hour sooner. that's the difference between having breakfast with your kids are not. having dinner with your kids or not. is where we think the nexus of safety comes together. so sort of pick up on something that john and those of the uta mentioned yesterday. we think a strong message that needs to be sent out there it is that if you really need to text, you really need t

the fda hasn't licensed it. you wanted to make drugs save and that's my concern, i'm sure everyone's concern on this panel. are we missing something here? is it something we should look at closer? >> it's something we should look at closely and i believe that the fda is doing this in good faith manner. i think when you think about who we are targeting for this vaccine, the bulk of the data for using this adjuvants vaccine and occurs with the elderly, that's not his targeted in this vaccine so we're just beginning to get the kind of data would be associated with kids. but i think the larger question is we have so much maxine hesitancy in this country. so much inaccurate knowledge about whether vaccines are safe and particularly whether this blue vaccine is safe. to add onto emergency use application, a new element that may, indeed, be saved could well have undermined the efficacy of this campaign. >> so this one has been around for since 97 or so and been approved. would it be prudent to maybe leave the decision